| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |